[Progestagen therapy of menometrorrhagias caused by hemorrhagic diatheses].
D000293:Adolescent; D000328:Adult; D001791:Blood Platelet Disorders / Q000150:complications; D002648:Child; D005260:Female; D006474:Hemorrhagic Disorders / Q000150:complications*; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use*; D008595:Menorrhagia / Q000188:drug therapy / Q000209:etiology; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008796:Metrorrhagia / Q000188:drug therapy / Q000209:etiology; D013921:Thrombocytopenia / Q000150:complications; D014842:von Willebrand Diseases / Q000150:complications
D008234:Lynestrenol
Progestagen-Behandlung von Menometrorrhagien infolge hämorrhagischer Diathesen.